Insights & Resources
Expert guidance on compounding, wellness and personalized medicine.
FDA Regulation
What the Recent Peptide Nomination Withdrawals Mean
The FDA just removed BPC-157, TB-500, and MOTS-c from its restricted compounding list — but it's not a green light yet. Here's what changed, what's next, and where we stand.